Aligos Therapeutics has announced an exclusive license agreement with Xiamen Amoytop Biotech Co., Ltd. for the development and commercialization of pevifoscorvir sodium in Greater China to treat chronic hepatitis B virus infection. Aligos will receive an upfront payment of $25 million USD and is eligible for up to $420 million USD in milestones, plus tiered royalties. This partnership leverages Amoytop's strong presence in the Chinese hepatology market, aiming to accelerate the development and regulatory success of pevifoscorvir sodium in a region with over 90 million people living with HBV.

Antero Midstream Corporation (NYSE:AM) has announced a quarterly dividend of $0.225 per share, payable on May 13th to shareholders of record on April 29th. The dividend yields approximately 4.2% annually, though its coverage is noted as potentially at risk with an 81.8% payout ratio and a recent EPS miss. Despite insider selling, institutional investors hold a significant portion of the company's stock.

Ally Financial Inc. announced a quarterly dividend of $0.30 per share, payable on May 15th to shareholders of record on May 1st. This dividend represents an annualized yield of 2.8% and is well-covered by earnings, with a payout ratio of 22.1%. The company recently exceeded Q4 earnings estimates and analysts maintain a "Moderate Buy" rating with an average price target of $53.29.

CNBC's 'Final Trades' segment highlighted several stocks, with analysts making recommendations. Netflix (NFLX) was chosen ahead of its Q1 earnings report, while Zoom Communications (ZM) and Apollo Global Management (APO) also received endorsements. Additionally, Invesco QQQ Trust (QQQ) was mentioned as a final trade.

This page focuses on the free cash flow for Western Asset Premier Bond Fund, traded on NASDAQ under the symbol XWEAX. Although specific financial data is not displayed, the article indicates that this information, along with other financial metrics, can be accessed through the platform. It provides an overview of the fund within the context of market data and financial tools available on TradingView.

This article provides trade ideas for the ProShares Ultra FTSE China 50 ETF (AMEX:XPP), noting its composition of 50 large, liquid Chinese stocks. One specific trade idea suggests the ETF is oversold, highlighted by unusual trading volume. The article also includes performance metrics such as 52-week low and high percentages and year-to-date performance.

KeyCorp (NYSE:KEY) reported better-than-expected Q1 CY2026 results, with sales up 10.2% year-on-year to $1.95 billion, surpassing Wall Street's revenue estimates. The company's non-GAAP profit of $0.44 per share also beat analyst consensus, despite its tangible book value per share missing estimates. Overall, the quarter was considered mixed by investors, with shares trading down slightly following the announcement.

U.S. Bancorp (NYSE:USB) reported its Q1 CY2026 earnings, meeting Wall Street's revenue expectations with a 4.7% year-on-year increase to $7.29 billion, and itsGAAP profit of $1.18 per share surpassed analyst estimates by 3.3%. The company's net interest margin and tangible book value per share slightly missed forecasts, resulting in a mixed quarter. Despite the mixed results, the stock remained flat immediately following the announcement at $56.49.

Charles Schwab Corp. exceeded first-quarter asset estimates, drawing in $139.9 billion in net new assets, a 5.7% increase from the previous year, surpassing analyst predictions of $123.5 billion. The brokerage also reported net income of $2.48 billion, slightly above the $2.46 billion forecast, demonstrating its continued ability to attract retail investor wealth despite global uncertainties.

KeyCorp's stock traded lower despite beating first-quarter earnings estimates, as its net interest margin fell short of consensus expectations. The company reported GAAP EPS of $0.44, exceeding estimates by $0.03, and revenue of $1.95 billion, beating by $10 million, representing a 10.2% year-over-year increase. Shares dropped 1.44% to $21.26 in pre-market trading following the news.